Mary Katherine Llarena
Nurse Practitioner · Santa Maria, CANPI 1447793211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 286 payments — averaging $29.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Merck$681
- Boehringer Ingelheim$599
- Esperion Therapeutics, Inc.$550
- AstraZeneca$472
- Novartis$430
- plus $4K from 28 others
What the payments were for
- Food & beverage$8,378100%
- Education$290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 72 | $1,359 |
| Merck | 21 | $681 |
| Boehringer Ingelheim | 18 | $599 |
| Esperion Therapeutics, Inc. | 22 | $550 |
| AstraZeneca | 21 | $472 |
| Novartis | 23 | $430 |
| Boston Scientific | 5 | $417 |
| Novo Nordisk | 4 | $381 |
| Lilly USA, LLC | 3 | $372 |
| AbbVie | 4 | $326 |
| Kiniksa Pharmaceuticals International, PLC | 9 | $323 |
| Alnylam Pharmaceuticals Inc. | 12 | $317 |
| Pfizer | 33 | $312 |
| Teva Pharmaceuticals USA, Inc. | 2 | $230 |
| E.r. Squibb & Sons, L.L.C. | 4 | $181 |
| Medtronic | 2 | $145 |
| Bayer | 7 | $132 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $121 |
| Idorsia Pharmaceuticals US Inc | 1 | $114 |
| Ascensia Diabetes Care US Inc. | 2 | $111 |
| Atricure, Inc. | 1 | $107 |
| Inspire Medical Systems, Inc. | 1 | $107 |
| Johnson & Johnson | 4 | $85 |
| Aimmune Therapeutics, Inc. | 1 | $81 |
| Actelion Pharmaceuticals US, Inc. | 1 | $77 |
| Eisai Inc. | 1 | $61 |
| Abiomed | 2 | $48 |
| Lexicon Pharmaceuticals, Inc. | 2 | $46 |
| Amarin Pharma, Inc. | 2 | $39 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| Biotronik Inc. | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$278
- Repatha$248
- JARDIANCE$248
- MOUNJARO$247
- VERQUVO$247
- ARCALYST$221
- NEXLIZET$217
- NEXLETOL$217
- LINQ II$139
- Austedo XR$125
- REZDIFFRA$123
- LOKELMA$121
- NURTEC ODT$121
- UBRELVY$120
- EVENITY$115
- QUVIVIQ$114
- WINREVAIR$112
- ELIQUIS$109
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$107
- Inspire$107
How this compares
$8,407 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Santa Maria
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.